Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v26-FR Version v10-FR
Language French French
Date Updated 2020-12-22 2017-07-21
Drug Identification Number 02212234 02212234
Brand name FORTAZ - INJ 6G/VIAL FORTAZ - INJ 6G/VIAL
Common or Proper name Ceftazidime for injection Ceftazidime for injection
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients CEFTAZIDIME CEFTAZIDIME
Strength(s) 6G 6G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 6's 6's
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-07-20 2017-07-20
Estimated end date 2019-01-01
Actual end date 2020-12-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments This product has been discontinued. FORTAZ® Injection 1g and 2g are available.
Health Canada comments